Pharmaceutical giant Sanofi has announced plans to restructure its operations in the United States, specifically focusing on its vaccines division. The company intends to overhaul its US operations in an effort to streamline its business and improve efficiency.
As part of this restructuring, Sanofi will be cutting jobs within its US vaccine operations. The exact number of jobs to be eliminated has not been disclosed, but the company has stated that the move is necessary to align its workforce with its new strategic direction.
